Regencell Bioscience Holdings Ltd

NASDAQ RGC

Download Data

Regencell Bioscience Holdings Ltd Depreciation and Amortization 3 year CAGR for the year ending June 30, 2023: 332.47%

Regencell Bioscience Holdings Ltd Depreciation and Amortization 3 year CAGR is 332.47% for the year ending June 30, 2023, a 483.63% change year over year. Depreciation and Amortization involve the systematic allocation of the cost of tangible and intangible assets over their useful lives. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Regencell Bioscience Holdings Ltd Depreciation and Amortization for the year ending June 30, 2022 was USD 604.40 K, a 2,184.54% change year over year.
  • Regencell Bioscience Holdings Ltd Depreciation and Amortization for the year ending June 30, 2021 was USD 26.46 K, a 178.02% change year over year.
  • Regencell Bioscience Holdings Ltd Depreciation and Amortization for the year ending June 30, 2020 was USD 9.52 K.
NASDAQ: RGC

Regencell Bioscience Holdings Ltd

CEO Mr. Yat-Gai Au
IPO Date July 16, 2021
Location Hong Kong
Headquarters First Commercial Building, Causeway Bay, Hong Kong
Employees 12
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Similar companies

EGRX

Eagle Pharmaceuticals Inc

NA

NA

PAHC

Phibro Animal Health Corporation

NA

NA

PROC

Procaps Group SA

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email